scholarly journals CRISPR knock out of programmed cell death protein 1 enhances anti-tumor activity of cytotoxic T lymphocytes

Oncotarget ◽  
2017 ◽  
Vol 9 (4) ◽  
pp. 5208-5215 ◽  
Author(s):  
Zhilong Zhao ◽  
Long Shi ◽  
Wei Zhang ◽  
Jinsheng Han ◽  
Shaohui Zhang ◽  
...  
Keyword(s):  
Cell Death ◽  
T Lymphocytes ◽  
Programmed Cell Death ◽  
Cytotoxic T Lymphocytes ◽  
Knock Out ◽  
Anti Tumor Activity ◽  
Cell Death Protein

CRISPR knock out CTLA-4 enhances the anti-tumor activity of cytotoxic T lymphocytes

Gene ◽  
2017 ◽  
Vol 636 ◽  
pp. 36-41 ◽  
Author(s):  
Long Shi ◽  
Tongyu Meng ◽  
Zhilong Zhao ◽  
Jinsheng Han ◽  
Wei Zhang ◽  
...  
Keyword(s):  
T Lymphocytes ◽  
Cytotoxic T Lymphocytes ◽  
Knock Out ◽  
Anti Tumor Activity

scholarly journals Prognostic value of programmed cell death protein 1 expression on CD8+ T lymphocytes in pancreatic cancer

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Tao Shen ◽  
Liangjing Zhou ◽  
Hua Shen ◽  
Chengfei Shi ◽  
Shengnan Jia ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cell Death ◽  
T Lymphocytes ◽  
Programmed Cell Death ◽  
Prognostic Value ◽  
Cd8 T Lymphocytes ◽  
Cell Death Protein

scholarly journals Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation

2020 ◽  
Vol 9 (1) ◽  
pp. 1738797 ◽  
Author(s):  
Ieva Saulite ◽  
Desislava Ignatova ◽  
Yun-Tsan Chang ◽  
Christina Fassnacht ◽  
Florentia Dimitriou ◽  
...  
Keyword(s):  
Cell Death ◽  
T Lymphocytes ◽  
Programmed Cell Death ◽  
Sézary Syndrome ◽  
Tumor Proliferation ◽  
Sezary Syndrome ◽  
Cell Death Protein
Sign in / Sign up

Export Citation Format

Share Document